kidney cancer

(Stanford University Medical Center) Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ.

But that could change, thanks to a new molecule found by Stanford University School of Medicine researchers that kills kidney cancer cells.

HOUSTON -- The tumor-derived vaccine vitespen (Oncophage) does not prevent kidney cancer recurrence or improve survival despite promising early results, researchers said.

NEW YORK -- When he was diagnosed with kidney cancer last year, Dave deBronkart needed an easy way to keep his far-flung friends and family updated.

So did the president of the American Medical Association when he fell ill months ago. And so did the mother of a soldier wounded in Iraq who later...

NEW YORK (AP) -- When he was diagnosed with kidney cancer last year, Dave deBronkart needed an easy way to keep his far-flung friends and family updated.

So did the president of the American Medical Association when he fell ill months ago. And so did the mother of a soldier wounded in Iraq who later suffered brain damage....

(University of California - San Diego) Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.

More kidney cancers in the United States are being diagnosed at early, highly treatable stages, and more patients are surviving the disease, a national study confirms.

(Memorial Sloan-Kettering Cancer Center) New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.

Consumption of acrylamide -- a chemical found in some common foods -- may be linked to kidney cancer, a study shows.

Male kidney cancer deaths have fallen by 13 percent across Europe since they peaked in the early 1990s and women have benefited from a 17 percent reduction.

But the study of 32 countries, based on data from the World Health Organization, has revealed wide variations between countries.